Pfizer's Covid-19 vaccine candidate offers protection after the first dose, according to documents released by the Food and Drug Administration Tuesday morning. The information was made public ahead of a Thursday meeting of an advisory group to the FDA, which will vote on whether to advise the agency to grant emergency use authorization of the vaccine in the U.S. |
No comments:
Post a Comment